Lupin#39;s Aurangabad facility receives EIR from US regulator News News / News 6 years ago 558 Views comments The facility was inspected by US FDA in April this year. The US drug regulator made eight Form 483 observations. Read more
News Spark Capital initiates buy on PSP Projects, target Rs 640; expects healthy free cash flow News / News - 6 years ago
News ICICI Pru Life begins valuation of Sahara Life liabilities for takeover of business News / News - 6 years ago
News Progress report on smart cities say Pune the biggest gainer, Chennai lags News / News - 6 years ago
Comments